ℹ️ Compiled from public regulatory records · Last regulator revision: June 17, 2025🚩 Report this page
Dextran 70
Active ingredient
Sold as TEARS NATURALE II · TEARS NATURALE FORTE
GB MHRACA Health Canada
- Drug class
- -
- Availability
- See label
- Routes
- Ophthalmic
- Markets covered
- 2
- Products on record
- 5
Overview
Dextran 70 is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | May 30, 2025 |
| CA Canada | Health Canada | 4 | June 17, 2025 |
GBUnited Kingdom· MHRA
1 product
Uses
Initial treatment of hypovolaemia with hypotension induced by traumatic injury
How to take
CACanada· Health Canada
4 products
4 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (2)
Sources & citations
- [1]MHRA (UK) · PL530190001 · revised May 30, 2025
- [2]Health Canada (DPD) · 00743445 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.